CLEVELAND, Jan. 7, 2013 /PRNewswire/ -- D ATATRAK International, Inc. (OTCQX: DATA), a leader in developing cloud-based, unified eClinical® technologies and delivering related services for the clinical trials industry, today announced it will soon be trading as DTRK. The new symbol more closely aligns with the company name and will be active January 9, 2013.
"Changing our stock symbol is just one small part of recapturing D ATATRAK's leadership position within the eClinical space," stated Laurence P. Birch, D ATATRAK's Chairman and CEO. "We begin 2013 strategically positioned to deliver perhaps our most impactful software release – our new D ATATRAK ONE™ user interface. The user interface is an extension of our new corporate branding and includes improved workflows, enhanced efficiencies, greater flexibility and more user-friendly features."
Birch continued, "Not only is our 'out of the box' technology offered at a lower cost but due to its simplicity in design, D ATATRAK ONE™ provides easy to deploy mid-study changes, higher site compliance and increased patient safety, resulting in a truly lower total cost of ownership. D ATATRAK ONE™ is safely accelerating clinical trial development activities."About DATATRAK DATATRAK is the leader of unified eClinical™ technologies and related services for the clinical trials industry. Using the D ATATRAK ONE™ multi-product, cloud-based clinical research platform, D ATATRAK 's Clinical and Consulting Services™ group assists clients in conducting Phase I-IV drug and device studies in multiple languages throughout the world. D ATATRAK has offices located in Cleveland, Ohio; Bryan, Texas; and Cary (RTP), North Carolina. For more information, visit www.datatrak.net. Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's report filed with the OTCQX Market on November 14, 2012 announcing its results for the three-month period ending September 30, 2012. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise. SOURCE DATATRAK International, Inc.